Dog therapy for dementia: can fluffy friends help with thinking and memory problems?

james-barker-v3-zcCWMjgM-unsplash

Dementia is an umbrella term used to describe the difficulties of thinking and memory caused by neurodegenerative diseases. It is estimated that around 50 million people are living with dementia worldwide, while one of the most common causes is Alzheimer’s Disease (AD), which accounts for more than half of these cases (Alzheimer’s Society, 2020).

To date there have been no new pharmacological interventions shown to significantly halt disease progression or cure it entirely (Ritchie et al., 2016). Research into alternative therapies are therefore important both for those living with dementia and their carers. Watch the Mental Health Question Time discussion on Dementia: Care or Cure? for a fascinating exploration of these issues.

Animal therapy seems to have a positive effect on children with ADHD and may help reduce stress levels in children and older adults (Lundqvist, 2017). Evidence summarised on other elf blogs about the mental health benefits of pets, include one by Alison Faulkner that highlighted the supportive effects that pets can have on people living with poor mental health (Faulkner, 2017).

A recent systematic review by Klimova et al. (2019) aimed to investigate the literature surrounding animal assisted therapy (AAT) for people living with dementia, with a specific focus on dog therapy. Generally, the AAT intervention uses interaction with an animal as part of the treatment plan and the authors mentioned a particular interest in the effects dog therapy would have on cognition and behaviour of those living with dementia. Dogs and cognitive assessments? I simply had to look into a paper written on my two favourite things.

Animals have been found to be helpful for people living ADHD or poor mental health, could dogs be beneficial for people living with dementia?

Animals have been found to be helpful for people living with ADHD or poor mental health, so could dogs be beneficial for people living with dementia?

Methods

Two researchers searched three databases and selected articles based on the following criteria:

Inclusion criteria

  • The articles had to be published between January 1, 2016, and August 31, 2018
  • Only English peer-reviewed journal articles were involved
  • The subjects had to be patients with dementia
  • The intervention had to include dog therapy
  • Only randomised controlled trials, experimental/cross-sectional studies, case reports, or observational studies were involved
  • The primary outcome focused on the reduction of dementia symptoms, especially cognitive decline among patients with dementia.

A reverse search of the references of included articles and a Google search of the key search terms were also completed.

Exclusion criteria

Articles were excluded if they were descriptive studies or reviews, if studies included patients without dementia or did not focus on dog therapy.

Results

Six studies were included in the systematic review. Most of the papers included in the review focused on behavioural outcomes. Only one paper is listed as reporting a cognitive outcome, although the Mini-Mental State Exam (MMSE) is included in three papers, and the Clinical Dementia Rating scale in one which suggests cognition was measured in these studies. The interventions included in the systematic review ranged from as little as 2 weeks for some studies and a long as 6 months in another. Studies included participants with varying degrees of dementia severity. Most papers were assessed to be good quality, although the authors did identify one paper as less reliable.

Cognitive outcomes

The mean MMSE score significantly increased from baseline to follow-up in the paper reporting a cognitive outcome. We do not have any significant results reported for the other two studies which measured cognition and it is not possible to tell from this systematic review whether the outcomes were reported or not by the original study authors.

Behavioural outcomes

There was a much more consistent result reported across studies when considering behavioural outcomes. All studies found a significant positive impact on mental and physical health of the people living with dementia after enrolment in an animal assisted therapy trial.

Dog therapy had a positive impact on mental and physical health in all 6 studies included, with limited evidence available for possible effects on cognition.

Dog therapy had a positive impact on mental and physical health in all 6 studies included, with limited evidence available for possible effects on cognition.

Conclusions

The authors concluded:

 […] results of all identified studies indicate that the AAT (animal assisted therapy) or AAA (animal assisted activity) therapies with a dog have a positive impact on mental and physical health of the subjects with dementia.

New systematic review suggests promising results on the effectiveness of dog therapy for people living with dementia, while highlights new research paths to other clinical populations.

New systematic review suggests promising results on the effectiveness of dog therapy for people living with dementia, and highlights new research paths for other clinical populations.

Strengths and limitations

The authors clearly worked hard to ensure that they had included all relevant literature including thorough database searches, reference lists and Google. It is a shame then that only six papers were identified, perhaps this systematic review was a little premature and with time more research studies would have been carried out to be included in the paper.

The authors included studies specifically targeting people living with dementia and excluded studies focusing on other mental health disorders. Therefore, the reader can deduce a clear understanding of the effect that dog therapy has on people living with dementia. However, only a proportion of the studies included specifically described the pathology as Alzheimer’s Disease, whereas others merely stated ‘dementia’. So, for example, someone living with Lewy Body Dementia, which can affect motor symptoms including balance, might have responded differently to this therapy compared to someone with Alzheimer’s Disease. The same can be said for dementia severity. Comparing studies including those with mild dementia to studies including people living with serve dementia will not be conducive to giving us a clear picture of the potential benefits of this therapy.

Furthermore, the authors stated that only one paper had explored cognition based on the Mini-Mental State Exam (MMSE) when in fact cognitive outcomes were investigated in four studies. It would have been interesting to see these discussed in more detail in the results. The MMSE is a commonly used screening tool which is great at telling us who may have dementia, but I would argue that it is not so great at closely measuring cognition. Call me biased (my day job is being a psychometric rater), but I would suggest that a more nuanced cognitive assessment would be needed to tease out any significant changes in cognition for people living with dementia. This would be a criticism for the investigators designing the studies as a whole though.

Lastly, there were some spelling and grammatical errors that occasionally made it difficult to interpret the article.

Future studies should aim to use more sensitive measures of cognition in order to accurately capture differences post-intervention.

Future studies should aim to use more sensitive measures of cognition in order to accurately capture differences post-intervention.

Implications for practice

What grabbed my attention in this review was the notion that AAT (animal assisted therapy) could have an impact on thinking and memory problems of people living with dementia. Cognitive dysfunction however, is only one part of a myriad of difficulties someone living with dementia might face. This systematic review highlighted that participants may have benefited psychologically with improvements on depression, quality of life assessments, and decreased levels of agitation or aggression. This is an important finding which merits further investigation.

Scotland’s National Dementia Strategy 2017-2020 highlighted the importance of responding to stress and distress effectively in people living with dementia and decreasing the use of inappropriate prescribing of antipsychotic mediation. Animal assisted therapy appears to have a positive effect on behaviour and few side effects or contraindications, well maybe some additional hoovering for a particularly fluffy friend.

If animal assisted therapy was rolled out more widely across care homes, I wonder if we would see a reduction in antipsychotic medication use? It is hard to draw firm conclusions from this systematic review alone, but the research adds some interesting insights and may prompt further investigation into AAT for people living with dementia.

Animal Assisted Therapy may reduce levels of agitation in people living with dementia, which could also help to decrease antipsychotic medication usage in the future.

Animal Assisted Therapy may reduce levels of agitation in people living with dementia, which may also help to decrease antipsychotic medication usage in the future.

Links

Primary paper

Klimova, B., Toman, J. & Kuca, K. (2019) Effectiveness of the dog therapy for patients with dementia – a systematic review. BMC Psychiatry 19, 276 (2019). https://doi.org/10.1186/s12888-019-2245-x

Other references

Ritchie, C. W., Molinuevo, J. L., Truyen, L., Satlin, A., Van der Geyten, S., & Lovestone, S. (2016). Development of interventions for the secondary prevention of Alzheimer’s dementia: the European Prevention of Alzheimer’s Dementia (EPAD) project. The Lancet Psychiatry, 3(2), 179-186.

Lundqvist, M., Carlsson, P., Sjödahl, R., Theodorsson, E., & Levin, L. Å. (2017). Patient benefit of dog-assisted interventions in health care: a systematic review. BMC complementary and alternative medicine, 17(1), 358.

Facts for the media. Alzheimer’s Society. (2020) Retrieved from: https://www.alzheimers.org.uk/about-us/news-and-media/facts-media

Faulkner, A. (2017). The role of pets in supporting people living with mental distress. Mental Elf. Last accessed: 24 July 2020.

Scotland’s National Dementia Strategy 2017-2020

Photo credits

Share on Facebook Tweet this on Twitter Share on LinkedIn Share on Google+
Mark as read
Create a personal elf note about this blog
Profile photo of Clare Dolan

Clare Dolan

Clare is a research assistant at the University of Edinburgh working as a psychometric rater across various studies at Edinburgh Dementia Prevention. She conducts cognitive assessments with healthy volunteers at varying risks of developing dementia and those living with neurodegenerative disease. Clare gained a Bachelor of Arts degree in Psychology and a Master of Science in Clinical Health Psychology at the University of Strathclyde whilst working as a health care assistant in both community and hospital settings. Before starting with Edinburgh Dementia Prevention, she worked in continuing care of the elderly and dementia assessment wards, which sparked her interest in dementia prevention research. In addition, Clare co-ordinates the participant panel for the PREVENT dementia research study in Edinburgh. She works in collaboration with the panel members to ensure the opinions of the participants guide the future directions of research programme.

More posts

Follow me here –

Profile photo of Sarah Gregory

Sarah Gregory

Sarah is a doctoral candidate and study coordinator at the University of Edinburgh. She has previously completed a Psychology BSc at University of Bath and Mental Health Science Research MSc at University College London. Sarah currently coordinates the European Prevention of Alzheimer’s Dementia (EPAD) and PREVENT Dementia studies at the Edinburgh Dementia Prevention centre, which are large mid-life studies aimed at understanding and developing interventions for Alzheimer’s disease dementia. Previously she was Deputy Manager of the West London Mental Health Trust Clinical Research Facility. Her PhD topic is looking at stress and stress biomarkers as a mid-life risk for Alzheimer’s disease. Sarah is also a lay member of the South East Scotland Research Ethics Committee 2, having previously sat on the Queens Square Research Ethics Committee, and is passionate about medical research ethics.

More posts

Follow me here –